MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 281

Keywords: Olfactory dysfunction, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson’s disease (PD).

Background: Hyposmia is quite a common finding in PD patients, notably in de novo patients. The fact that many patients with an established clinical diagnosis of PD recall a loss of or reduction of the sense of smell that started years before the onset of motor parkinsonism and the reports of hyposmia in asymptomatic first-degree relatives of patients with familial forms of parkinsonism or with sporadic PD suggest that an olfactory deficit might be a premotor sign in PD.

Methods: The Parkinson’s Progression Markers Initiative (PPMI) is a multi-site, prospective study which aims to identify biomarkers in PD. Assessments include the International Parkinson and Movement Disorders Society Unified Parkinson’s disease Rating Scale (MDS-UPDRS) Part I items on cognitive impairment, hyposmia, pain, autonomic nerve system disorders, sleep disorders and neuropsuchiatric disturbances. All participants completed Smell Diskettes Identification test (SDIT) a measure of olfaction. Binary logistic regression was used to examine the relationship between hyposmia and presence of nonmotor features (MDS-UPDRS Part 1 items), controlling for baseline age, disease duration, gender, and years of education.

Results: Individuals were categorized into 3 groups based on baseline SDIT score quartiles (range: 1-8). Compared to normosmics, those in the lowest quartile had 4 times the odds of reporting cognitive difficulties (OR=4.15, 95%CI: 1.96-8.78, p<.05) and twice the odds of reporting anxiety (OR=2.24, 95%CI: 1.21-4.15, p<.05).

Conclusions: Olfactory tests could be useful in the early diagnosis of PD and detected hyposmia is a significant predictor of self-reported cognitive difficulties and anxiety. Idiopathic hyposmia in elderly individuals constitutes a risk of developing PD and promote further study of the impact of hyposmia in PD.

To cite this abstract in AMA style:

M. Sanoeva, N. Mansurova, A. Prokhorova. Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/hyposmia-as-a-predictor-of-non-motor-symptom-in-patients-with-de-novo-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hyposmia-as-a-predictor-of-non-motor-symptom-in-patients-with-de-novo-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley